FDA Center for Drug Evaluation & Research Issues Warning Letter to GC America
May 27, 2026
May 27, 2026
WASHINGTON, May 27 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to GC America Inc. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Joseph T. Talanges, President & Chief Operating Officer, GC America, Inc., 3737 West 127th Street, Alsip, IL 60803, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LE . . .
* * *
Recipient: Mr. Joseph T. Talanges, President & Chief Operating Officer, GC America, Inc., 3737 West 127th Street, Alsip, IL 60803, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LE . . .